Eupraxia Pharmaceuticals Inc.

Eupraxia Pharmaceuticals Inc.verified

EPRXF

Price:

$3.04

Market Cap:

$217.47M

Eupraxia Pharmaceuticals Inc. operates as a clinical-stage biotechnology firm, focusing its efforts on the discovery, advancement, and commercialization of innovative technologies within the biotech landscape. The company's leading therapeutic compound, EP-104IAR, is currently progressing through Phase II clinical trials. This candidate is designed to address pressing unmet medical needs and provide pain relief for individuals suffering from knee osteoarthritis. Additionally, its potential is being explored for the treatment of osteoarthritis in animal companions, specifically dogs and horses. Eupraxia's development pipeline also features other significant programs, including EP-201, an anti...[Read more]

Industry

Biotechnology

IPO Date

2021-08-03

Stock Exchange

OTC

Ticker

EPRXF

The Enterprise Value as of June 2026 (TTM) for Eupraxia Pharmaceuticals Inc. (EPRXF) is 160.94M

According to Eupraxia Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 160.94M. This represents a change of -54.55% compared to the average of 354.10M of the last 4 quarters.

Eupraxia Pharmaceuticals Inc. (EPRXF) Historical Enterprise Value (quarterly & annually)

How has EPRXF Enterprise Value performed in the past?

The mean historical Enterprise Value of Eupraxia Pharmaceuticals Inc. over the last ten years is 114.46M. The current 160.94M Enterprise Value has changed 13.96% with respect to the historical average. Over the past ten years (40 quarters), EPRXF's Enterprise Value was at its highest in in the March 2026 quarter at 512.86M. The Enterprise Value was at its lowest in in the September 2019 quarter at 0.

Quarterly (TTM)
Annual

Average

114.46M

Median

99.55M

Minimum

23.50M

Maximum

332.08M

Eupraxia Pharmaceuticals Inc. (EPRXF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Eupraxia Pharmaceuticals Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 176.74%

Maximum Annual Enterprise Value = 332.08M

Minimum Annual Increase = -76.83%

Minimum Annual Enterprise Value = 23.50M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025332.08M176.74%
2024120.00M-0.76%
2023120.91M115.14%
202256.20M139.20%
202123.50M-76.83%
2020101.39M1.85%
201999.55M8.51%
201891.74M8.19%

Eupraxia Pharmaceuticals Inc. (EPRXF) Average Enterprise Value

How has EPRXF Enterprise Value performed in the past?

The current Enterprise Value of Eupraxia Pharmaceuticals Inc. (EPRXF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

191.00M

5-year avg

130.54M

10-year avg

114.46M

Eupraxia Pharmaceuticals Inc. (EPRXF) Enterprise Value vs. Peers

How is EPRXF’s Enterprise Value compared to its peers?

Eupraxia Pharmaceuticals Inc.’s Enterprise Value is greater than Adocia S.A. (75.41M), greater than Prescient Therapeutics Limited (62.23M), greater than BioHarvest Sciences Inc. (110.08M), less than Anteris Technologies Ltd (331.11M), less than Ascentage Pharma Group International (10.57B), greater than Mind Cure Health Inc. (112.12M), greater than Leafly Holdings, Inc. (132.00M), greater than E-therapeutics Plc (36.43M), less than Lee's Pharmaceutical Holdings Limited (584.54M), greater than Herantis Pharma Oyj (53.64M),

Build a custom stock screener for Eupraxia Pharmaceuticals Inc. (EPRXF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eupraxia Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Eupraxia Pharmaceuticals Inc. (EPRXF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Eupraxia Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Eupraxia Pharmaceuticals Inc.'s Enterprise Value?

What is the highest Enterprise Value for Eupraxia Pharmaceuticals Inc. (EPRXF)?

What is the 3-year average Enterprise Value for Eupraxia Pharmaceuticals Inc. (EPRXF)?

What is the 5-year average Enterprise Value for Eupraxia Pharmaceuticals Inc. (EPRXF)?

How does the current Enterprise Value for Eupraxia Pharmaceuticals Inc. (EPRXF) compare to its historical average?